Publications by authors named "Praveen Kumar Royapalley"
Eur J Pharmacol
October 2011
Article Synopsis
- Nerve injuries, diabetes, and cancer therapies can lead to painful neuropathy, but current treatments are often ineffective and come with side effects.
- Tebanicline and A-366833 are nicotinic acetylcholine receptor agonists that have shown promise in reducing pain in various preclinical models.
- A-366833 was particularly effective in rat models of different types of pain, highlighting its potential as a broad-spectrum treatment for both neuropathic and inflammatory pain conditions.
